Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.

Javitz HS, Swan GE, Lerman C.

Addiction. 2011 Oct;106(10):1835-45. doi: 10.1111/j.1360-0443.2011.03495.x. Epub 2011 Aug 18.

PMID:
21561501
2.

Comparative dynamics of four smoking withdrawal symptom scales.

Javitz HS, Lerman C, Swan GE.

Addiction. 2012 Aug;107(8):1501-11. doi: 10.1111/j.1360-0443.2012.03838.x. Epub 2012 Apr 17. Review.

3.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
4.

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.

Gonzales D, Jorenby DE, Brandon TH, Arteaga C, Lee TC.

Addiction. 2010 Nov;105(11):2002-13. doi: 10.1111/j.1360-0443.2010.03058.x. Epub 2010 Sep 1.

5.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

6.

Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.

Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB.

Addiction. 2011 Feb;106(2):418-27. doi: 10.1111/j.1360-0443.2010.03173.x. Epub 2010 Oct 25.

7.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
8.

The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence.

Ashare RL, Wileyto EP, Perkins KA, Schnoll RA.

J Addict Med. 2013 Jul-Aug;7(4):249-54. doi: 10.1097/ADM.0b013e31829363e1.

9.

Outcomes from an outpatient smoking-cessation clinic.

Roth MT, Andrus MR, Westman EC.

Pharmacotherapy. 2005 Feb;25(2):279-88.

PMID:
15767242
10.

A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Xenakis JG, Kinter ET, Ishak KJ, Ward AJ, Marton JP, Willke RJ, Davies S, Caro JJ.

Pharmacoeconomics. 2011 Jun;29(6):497-510. doi: 10.2165/11589230-000000000-00000.

PMID:
21452908
11.

Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week.

Cofta-Woerpel L, McClure JB, Li Y, Urbauer D, Cinciripini PM, Wetter DW.

J Abnorm Psychol. 2011 Aug;120(3):596-606. doi: 10.1037/a0023755.

12.

The transdermal nicotine patch: results of a randomised placebo-controlled trial.

Richmond RL, Harris K, de Almeida Neto A.

Med J Aust. 1994 Jul 18;161(2):130-5.

PMID:
8028537
14.

Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).

Cabezas C, Advani M, Puente D, Rodriguez-Blanco T, Martin C; ISTAPS Study Group.

Addiction. 2011 Sep;106(9):1696-706. doi: 10.1111/j.1360-0443.2011.03491.x. Epub 2011 Jul 22.

PMID:
21561497
15.
16.

Transdermal nicotine for smoking cessation in postmenopausal women.

Oncken C, Cooney J, Feinn R, Lando H, Kranzler HR.

Addict Behav. 2007 Feb;32(2):296-309. Epub 2006 Jun 12.

PMID:
16765526
17.

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

Ann Intern Med. 2009 Apr 7;150(7):447-54.

PMID:
19349630
18.

Predictive factors in smoking cessation with combined therapy with bupropion and nicotine patches.

Sampablo I, Lores L, Coll-Klein F, Jimenez C, Rebasa P.

Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):171-6.

PMID:
14635510
19.

Smoking characteristics and cessation in patients with thromboangiitis obliterans.

Jiménez-Ruiz CA, Dale LC, Astray Mochales J, Velázquez Buendía L, de Granda Orive I, Guirao García A.

Monaldi Arch Chest Dis. 2006 Dec;65(4):217-21.

PMID:
17393667
20.

The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.

Szatkowski L, Coleman T, McNeill A, Lewis S.

Addiction. 2011 Oct;106(10):1827-34. doi: 10.1111/j.1360-0443.2011.03494.x. Epub 2011 Jul 27.

PMID:
21561500
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk